BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 15895072)

  • 1. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.
    Muñoz-Elías EJ; McKinney JD
    Nat Med; 2005 Jun; 11(6):638-44. PubMed ID: 15895072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence.
    Muñoz-Elías EJ; Upton AM; Cherian J; McKinney JD
    Mol Microbiol; 2006 Jun; 60(5):1109-22. PubMed ID: 16689789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis.
    Upton AM; McKinney JD
    Microbiology (Reading); 2007 Dec; 153(Pt 12):3973-3982. PubMed ID: 18048912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.
    McKinney JD; Höner zu Bentrup K; Muñoz-Elías EJ; Miczak A; Chen B; Chan WT; Swenson D; Sacchettini JC; Jacobs WR; Russell DG
    Nature; 2000 Aug; 406(6797):735-8. PubMed ID: 10963599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual role of isocitrate lyase 1 in the glyoxylate and methylcitrate cycles in Mycobacterium tuberculosis.
    Gould TA; van de Langemheen H; Muñoz-Elías EJ; McKinney JD; Sacchettini JC
    Mol Microbiol; 2006 Aug; 61(4):940-7. PubMed ID: 16879647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling synergistic drug inhibition of Mycobacterium tuberculosis growth in murine macrophages.
    Fang X; Wallqvist A; Reifman J
    Mol Biosyst; 2011 Sep; 7(9):2622-36. PubMed ID: 21713281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
    Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
    Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
    Lee YV; Wahab HA; Choong YS
    Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNAzymes targeting the icl gene inhibit ICL expression and decrease Mycobacterium tuberculosis survival in macrophages.
    Li J; Zhu D; Yi Z; He Y; Chun Y; Liu Y; Li N
    Oligonucleotides; 2005; 15(3):215-22. PubMed ID: 16201909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the
    Ko EM; Kim JY; Lee S; Kim S; Hwang J; Oh JI
    J Bacteriol; 2021 Nov; 203(23):e0040221. PubMed ID: 34516281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-Based Inactivation of
    Mellott DM; Torres D; Krieger IV; Cameron SA; Moghadamchargari Z; Laganowsky A; Sacchettini JC; Meek TD; Harris LD
    J Am Chem Soc; 2021 Oct; 143(42):17666-17676. PubMed ID: 34664502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages].
    Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2.
    Bhusal RP; Jiao W; Kwai BXC; Reynisson J; Collins AJ; Sperry J; Bashiri G; Leung IKH
    Nat Commun; 2019 Oct; 10(1):4639. PubMed ID: 31604954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from
    Antil M; Gupta V
    Protein Pept Lett; 2022; 29(12):1031-1041. PubMed ID: 36201276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inactivator of isocitrate lyases 1 and 2 from
    Pham TV; Murkin AS; Moynihan MM; Harris L; Tyler PC; Shetty N; Sacchettini JC; Huang HL; Meek TD
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7617-7622. PubMed ID: 28679637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function insights into elusive Mycobacterium tuberculosis protein Rv1916.
    Antil M; Sharma J; Brissonnet Y; Choudhary M; Gouin S; Gupta V
    Int J Biol Macromol; 2019 Dec; 141():927-936. PubMed ID: 31505209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
    Höner Zu Bentrup K; Miczak A; Swenson DL; Russell DG
    J Bacteriol; 1999 Dec; 181(23):7161-7. PubMed ID: 10572116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.
    Shukla H; Kumar V; Singh AK; Rastogi S; Khan SR; Siddiqi MI; Krishnan MY; Akhtar MS
    Int J Biol Macromol; 2015; 78():137-41. PubMed ID: 25869309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiology. A weak link in TB bacterium is found.
    Helmuth L
    Science; 2000 Aug; 289(5482):1123-5. PubMed ID: 10970221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.